NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of HealthEquity, ...

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

HealthEquity (NASDAQ:HQY – Free Report) had its price objective trimmed by The Goldman Sachs Group from $107.00 to $94.00 in a report published on Thursday morning,Benzinga reports. The firm currently ...

Shares of HealthEquity (NASDAQ:HQY) fell ~20% on Wednesday, marking its biggest one-day decline in more than three years, ...

HealthEquity (NASDAQ:HQY – Get Free Report) was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Tuesday, MarketBeat.com ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS:HQY) from Outperform ...

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

In the last three months, 4 analysts have published ratings on HealthEquity HQY, offering a diverse range of perspectives ...

HealthEquity divulged its fourth-quarter and full-year fiscal 2024 results just after market close on Tuesday. Over the past few days HealthEquity (NASDAQ: HQY) shares have been rather sickly.

On Tuesday, HealthEquity, Inc. (NASDAQ:HQY) reported fourth-quarter adjusted EPS of 69 cents, up from 63 cents a year ago, missing the consensus of 72 cents. Revenue increased 19% year over year ...

The Draper, Utah., health-savings account custodian on Tuesday said it expects adjusted per-share earnings of $3.57 to $3.74 in its fiscal 2026, the midpoint of which is below the $3.71 that analysts ...

HealthEquity, Inc. (NASDAQ:HQY) reported fourth-quarter adjusted EPS of 69 cents, up from 63 cents a year ago, missing the consensus of 72 cents. Revenue increased 19% year over year to $311.8 million ...